You have 9 free searches left this month | for more free features.
Clincosm LogoSign in Get a demo

AMXT 1501

Showing 1 - 25 of 25
STUDY
CONDITIONS
INTERVENTIONS
LOCATIONS
LAST UPDATED

Diffuse Glioma, Malignant Glioma Trial in Rochester (Biospecimen Collection, Computed Tomography, Eflornithine)

Not yet recruiting
  • Diffuse Glioma
  • Malignant Glioma
  • Biospecimen Collection
  • +6 more
  • Rochester, Minnesota
    Mayo Clinic in Rochester
Feb 6, 2023

Cancer, Solid Tumor, Solid Carcinoma Trial in United States (AMXT1501, DFMO)

Active, not recruiting
  • Cancer
  • +3 more
  • Austin, Texas
  • +3 more
Jan 18, 2023

Cancer, Solid Tumor, Solid Carcinoma Trial in Houston (AMXT1501, DFMO)

Recruiting
  • Cancer
  • +18 more
  • Houston, Texas
    MD Anderson Cancer Center
Aug 12, 2022

Tumors, Medication Toxicity, Tolerance Trial in Overland Park (AMXT 1501, Placebo Oral Tablet)

Withdrawn
  • Neoplasms
  • +2 more
  • AMXT 1501
  • Placebo Oral Tablet
  • Overland Park, Kansas
    IQVIA (formerly Quintiles IMS)
Jun 12, 2018

High-risk NMIBC Trial (SHR-1501)

Recruiting
  • High-risk NMIBC
  • Beijing, Beijing, China
    Peking University First Hospital
Nov 28, 2022

Postoperative Pain Trial in Japan (SyB P-1501, SyB P-1501 )

Terminated
  • Postoperative Pain
  • SyB P-1501
  • SyB P-1501 placebo
  • Nagakute, Aichi, Japan
  • +28 more
Nov 14, 2022

Kidney Transplant Rejection Trial in Saint Louis, Richmond (AT-1501, Tacrolimus)

Recruiting
  • Kidney Transplant Rejection
  • Saint Louis, Missouri
  • +1 more
Aug 2, 2023

Kidney Transplant Rejection Trial in Montréal (AT-1501, Tacrolimus)

Enrolling by invitation
  • Kidney Transplant Rejection
  • Montréal, Quebec, Canada
    McGill University Health Care Centre
Nov 6, 2023

Bladder Cancer Trial in Melbourne (APL-1202 and APL-1501 (Single ascending dose), APL-1202 and APL-1501 (Multiple Ascending

Not yet recruiting
  • Bladder Cancer
  • APL-1202 and APL-1501 (Single ascending dose)
  • APL-1202 and APL-1501 (Multiple Ascending dose)
  • Melbourne, Victoria, Australia
    Nucleus Network Pty Ltd
Sep 11, 2023

Kidney Transplant Trial in Montréal (AT-1501)

Recruiting
  • Kidney Transplant
  • Montréal, Quebec, Canada
    McGill University Health Care Centre
May 16, 2022

Brittle Type 1 Diabetes Trial (AT-1501 IV Infusion, Isolated cadaveric islet cells)

Not yet recruiting
  • Brittle Type 1 Diabetes Mellitus
  • AT-1501 IV Infusion
  • Isolated cadaveric islet cells
  • (no location specified)
Jul 27, 2022

IgA Nephropathy, IgAN Trial in Worldwide (AT-1501)

Recruiting
  • IgA Nephropathy
  • IgAN
  • Liverpool, South Wales, Australia
  • +23 more
Dec 5, 2022

Lymphoblastic Leukemia, Acute Adult Trial in Japan (TBI-1501)

Active, not recruiting
  • Lymphoblastic Leukemia, Acute Adult
  • TBI-1501
  • Yoshida, Fukui, Japan
  • +10 more
Jun 15, 2022

Narcolepsy Type 1 (NT 1) Trial in Worldwide (TAK-994, Placebo)

Terminated
  • Narcolepsy Type 1 (NT 1)
  • Alabaster, Alabama
  • +69 more
Oct 5, 2022

Addiction, Opioid Dependence, Opioid Withdrawal Trial (APH-1501, Placebo)

Not yet recruiting
  • Addiction
  • +2 more
  • (no location specified)
Jul 26, 2021

Trigeminal Neuralgia Trial in Birmingham (Unframed Virtual Cone, 80 Gy Radiation)

Recruiting
  • Trigeminal Neuralgia
  • Unframed Virtual Cone
  • 80 Gy Radiation
  • Birmingham, Alabama
    Hazelrig-Salter Radiation Oncology Center
Sep 12, 2022

Type 1 Diabetes Trial in Edmonton (AT-1501)

Recruiting
  • Type 1 Diabetes Mellitus
  • Edmonton, Alberta, Canada
    University of Alberta
Sep 2, 2021

Bladder Cancer Trial in Randwick (APL-1202+APL-1501 ER Tablets 3+APL-1501 ER Tablets 2, APL-1501 ER Tablets 3+APL-1202+APL-1501

Completed
  • Bladder Cancer
  • APL-1202+APL-1501 ER Tablets 3+APL-1501 ER Tablets 2
  • APL-1501 ER Tablets 3+APL-1202+APL-1501 ER Tablets 2
  • Randwick, New South Wales, Australia
    Scientia clinical research
Jun 25, 2021

Acute GVHD Trial in United States (Sirolimus, Prednisone)

Completed
Has Results
  • Acute GVHD
  • Duarte, California
  • +20 more
Oct 20, 2021

Advanced Malignancies Trial in Beijing (SHR-1501)

Unknown status
  • Advanced Malignancies
  • Beijing, China
    Cancer hospital, Chinese academy of medical sciences
Jul 21, 2020

Cardiac Arrest, Cardiopulmonary Resuscitation Trial in France (Guidance of the External Chest Compression, Rhythm of a relay 4

Recruiting
  • Cardiac Arrest
  • Cardiopulmonary Resuscitation
  • Guidance of the External Chest Compression
  • Rhythm of a relay 4 minutes
  • Caen, Normandy, France
  • +10 more
Mar 21, 2022

Bioequivalence Trial in Toronto (Metronidazole Tablet)

Completed
  • Bioequivalence
  • Metronidazole Tablet
  • Toronto, Ontario, Canada
    INC Research Inc.
Jan 10, 2019

Gastric Ulcer Trial in Seoul (BRI-1501, Lafutidine, Irsogladine maleate)

Completed
  • Gastric Ulcer
  • Seoul, Korea, Republic of
    The Catholic University of Korea, Seoul St.Mary's Hospital
Feb 6, 2017

Infant, Very Low Birth Weight, Infant Malnutrition, Feeding Disorder of Infancy or Early Childhood Trial in Monza (different

Completed
  • Infant, Very Low Birth Weight
  • +4 more
  • different nutrional regimen
  • comparison of different feeding regimens
  • Monza, MonzaBrianza, Italy
    NICU San Gerardo Hospital
Mar 21, 2013

Melanoma Trial in Lebanon, Oklahoma City (852A)

Completed
  • Melanoma
  • Lebanon, New Hampshire
  • +1 more
Oct 24, 2008